GE Healthcare Technologies Inc
NASDAQ:GEHC
Net Margin
GE Healthcare Technologies Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
31.9B USD |
11%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
230.4B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
194.9B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
154.8B USD |
12%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
145.1B USD |
12%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.3B USD |
13%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
54.7B EUR |
9%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
49.6B USD |
7%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.8B USD |
75%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
40.4B USD |
23%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
274.8B CNY |
31%
|
GE Healthcare Technologies Inc
Glance View
GE Healthcare Technologies Inc. operates as a pivotal player in the vast landscape of medical technology, skillfully weaving a narrative that integrates cutting-edge innovation with practical application. As a segment originally spun out from the iconic General Electric Company, GE Healthcare focuses on enhancing diagnostics and patient care through its advanced imaging and monitoring systems. The company's portfolio spans a wide range of products, including magnetic resonance imaging (MRI) machines, ultrasound devices, and computed tomography (CT) scanners, each designed to provide medical professionals with critical insights needed for accurate diagnosis and effective treatment. By leveraging decades of engineering expertise and a rich history in innovation, GE Healthcare not only improves hospital efficiencies but also supports personalized healthcare solutions that help in the early detection and effective management of diseases. Their revenue model is primarily centered around the sale of these high-technology machines and the accompanying service agreements that ensure their seamless operation. Additionally, the company generates income from its work in life sciences, offering a suite of applications and software that assist in drug discovery and bioprocessing. Combining hardware sales with recurring revenue streams from maintenance services and digital solutions enhances the company’s financial stability. This multifaceted approach positions GE Healthcare as both a stalwart in existing medical technology fields and a pioneer exploring the frontiers of healthcare innovations, driven by a mission to improve patient outcomes worldwide.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on GE Healthcare Technologies Inc's most recent financial statements, the company has Net Margin of 11%.
You don't have any saved screeners yet